Objective: In the heart, there are multiple supraventricular pacemakers involved in normal pacemaking as well as arrhythmias and the objective was to determine the distribution of HCN4 (major isoform underlying the pacemaker current, I f ) in the atria. Methods: In the atria of the rat, the localisation of HCN4 and connexins was determined using immunohistochemistry, and electrical activity was recorded using extracellular electrodes. Results: As expected, HCN4 and Cx45 (but not Cx43) were expressed in the sinoatrial node extending from the superior vena cava down the crista terminalis. The same pattern of expression of HCN4 and connexins was observed in a novel tract of nodal-like cells extending from the superior vena cava down the interatrial groove. Although the sinoatrial node was usually the leading pacemaker site, the novel tract of HCN4-expressing cells was capable of pacemaking and could act as the leading pacemaker site; there was evidence of a hierarchy of pacemakers. The same pattern of expression of HCN4 and connexins was also observed in the atrioventricular ring bundle (including the atrioventricular node) encircling the tricuspid valve, but not in the atrioventricular ring bundle encircling the mitral valve. HCN4 was not expressed in the pulmonary veins. Conclusions: The widespread distribution of HCN4 can explain the widespread location of the leading pacemaker site during sinus rhythm, the extensive region of tissue that has to be ablated to stop sinus rhythm, and the widespread distribution of ectopic foci responsible for atrial tachycardia.
Introduction
In the heart, there are multiple supraventricular tissues capable of showing pacemaker activity including the sinoatrial node (SAN), atrioventricular node (AVN), superior vena cava [1] [2] [3] [4] , AV ring bundles [5] [6] [7] [8] [9] [10] [11] [12] and pulmonary veins [13] . These tissues constitute the normal pacemaker (SAN), back-up pacemakers (e.g. AVN) and ectopic foci (e.g. pulmonary veins) responsible for atrial tachycardia and fibrillation. The hyperpolarization-activated current, I f , plays a major role in pacemaker activity in the heart [14] and I f is known to play a significant role in the pacemaker activity of many of the atrial pacemakers [7, 15, 16] . Four cDNAs encoding I f -type currents have been cloned from vertebrates (HCN1-4); HCN4 has been reported to be a major isoform in the cardiac conduction system (SAN, AVN, Purkinje fibres) [15, 17, 18] . The aim of the present study was to determine the distribution of HCN4 in the atria. A characteristic feature of the SAN and AVN is that there is little or no expression of connexin43 (Cx43; medium conductance gap junction protein), which is abundantly expressed in the remainder of the heart, and instead there is expression of connexin45 (Cx45; low conductance gap junction protein). This results in poor electrical coupling in the nodal tissues and this is considered essential to protect the pacemaking tissue from the inhibitory electrotonic influence of the surrounding non-pacemaking atrial muscle [19] . The distribution of Cx43 and Cx45 in the atria was also determined in the present study. As well as in the SAN and AVN, HCN4 and Cx45 (but not Cx43) were expressed in tracts of nodal-like cells in the interatrial groove and around the tricuspid valve, but surprisingly not in the pulmonary veins.
Methods
Wistar rats (male; 250-300 g) and New Zealand white rabbits (male; 1.9-2 kg; used for histology and quantitative PCR) were sacrificed humanely according to the United Kingdom Animals (Scientific Procedures) Act, 1986; in addition, the investigation conformed with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) . For the recording of membrane potential from the pulmonary veins, Japanese white rabbits (of either sex; 1.5-2.0 kg) were anesthetized with pentobarbital (30-40 mg/kg, iv); animal procedures were approved by the Animal Care and Use Committee, Research Institute of Environmental Medicine, Nagoya University. Following death of the animals, the heart was quickly removed. From the rat hearts, the atria (or AV junction) were isolated. Some of the rat preparations were frozen and cryosectioned; the sections were subsequently stained with Masson's trichrome or immunolabelled for HCN4, Cx43 and Cx45 using standard techniques [20] . Alternatively, extracellular electrodes were used to measure the activation sequence and spontaneous beating rate of the rat atria [21] . One rabbit heart was frozen and cryosectioned and the sections stained with Masson's trichrome. From seven rabbit hearts, total RNA was isolated from the proximal and distal pulmonary veins and the right atrium; cDNA was generated from the total RNA. The relative abundance of HCN1 and HCN4 cDNA (a measure of the abundance of HCN1 and HCN4 mRNA in the original samples) was then measured with quantitative PCR. From three rabbit hearts, the right superior pulmonary vein was isolated and the membrane potential recorded with glass microelectrodes. Data are presented as means ± SEM. A one-or two-way ANOVA completed by a Bonferroni t-test was used to test differences; a difference was considered significant if P b 0.05. Further details of the techniques are available in the Electronic Supplementary Material. 
Results

Superior vena cava and rear wall of right atrium
Isolated atrial preparations were serially cryosectioned in a plane perpendicular to the axis from the superior to the inferior vena cava. Representative results from one heart are shown in Figs. 1-3 ; similar results were obtained from four hearts. Fig. 1 shows adjacent sections at the level of the junction of the superior vena cava with the right atrium (see inset in Fig. 1A) . The dorsal region of the junction showed strong red staining with Masson's trichrome, but in the ventral region, there were cells with paler staining (Fig. 1A) (Fig. 1D) . The strong Masson's trichrome-stained/HCN4-negative/Cx43-positive/Cx45-negative cells are atrial cells and the pale Masson's trichrome-stained/ HCN4-positive/Cx43-negative/Cx45-positive cells are SAN cells. Fig. 2 shows sections at a more inferior level ( Fig. 2A, inset) . At this level, there were two groups of nodal (or nodal-like) cells: a large group of nodal cells was located alongside the crista terminalis (this group constitutes the SAN [20] ) and a smaller group of nodal-like cells was located on the epicardial surface next to the interatrial groove. Fig. 2A shows that both groups (tissue within dashed lines in the main panel of Fig. 2A ) appeared pale when stained with Masson's trichrome (unlike surrounding atrial muscle). Fig. 2F shows that both groups (tissue within dashed lines in Fig. 2F ) showed strong expression of HCN4. Details of the HCN4 labelling are shown in Fig. 2D ,E. Both groups also showed expression of Cx45 and no expression of Cx43. As an example, Fig. 2C shows labelling of Cx43 and Cx45 in the nodal-like cells next to the interatrial groove -in these cells, note the close correspondence between the labelling of HCN4 and Cx45 ( superior vena cava: one arm of the U forms the SAN and the other forms a tract of nodal-like cells extending down the interatrial groove.
Functional importance of tract of HCN4-expressing nodal-like cells in interatrial groove
Under control conditions, the location of the leading pacemaker site was investigated in 18 preparations. Fig. 4 shows representative activation maps (epicardial views shown). In 11 of 18 preparations, the leading pacemaker site was located in the SAN next to the crista terminalis and Fig. 4A ,B shows two such examples (see left hand activation maps obtained under control conditions) -the leading pacemaker site (asterisk) was located on or next to the crista terminalis (grey shaded bundle) and the right sinoatrial ring bundle (RSARB). However, in the remaining seven preparations, the leading pacemaker site was located in the interatrial groove and Fig. 4C (left) shows one example -the leading pacemaker site (asterisk) is next to the left sinoatrial ring bundle (LSARB). Next, we investigated the effect of 0.05 μM isoproterenol (ISO) on the leading pacemaker site. In four of five preparations, the leading pacemaker site shifted from the SAN adjacent to the crista terminalis to the junction between the superior vena cava and the interatrial groove (ISO site) - Fig. 4A ,B shows examples. Of these four preparations, in the presence of ISO, two exhibited a permanent pacemaker shift to the ISO site and in the other two the leading pacemaker site shifted back and forth between the SAN and the ISO site. In one of five preparations, the leading pacemaker site shifted from the interatrial groove to the ISO site (Fig. 4C ). This distribution of leading pacemaker sites (under control conditions and in presence of ISO) corresponds to the distribution of HCN4 described above.
We compared the pacemaker activity of the SAN and the tract of nodal-like cells in the interatrial groove. Preparations were divided into two as shown in Fig. 5 (inset) . One part included the SAN and the other part included the interatrial groove ( Fig. 5, inset ; endocardial view of tissue shown). Under control conditions, after the division of the tissue into two, the preparation containing the interatrial groove showed spontaneous beating for a brief period (0.5-5 min), whereas the preparation containing the SAN showed continuous beating. The cycle length of the preparation including the SAN was 362 ± 26 ms and it was not changed by the separation of the tissue into two. In the presence of 0.05 μM ISO (Fig. 5A,  left) , the preparation including the interatrial groove started beating spontaneously and the cycle length was similar to that of the preparation including the SAN in the presence of ISO (166 ± 8 and 174 ± 8 ms, respectively; not significantly different). In the presence of 0.05 μM ISO, 2 mM Cs + was applied to block I f , for which HCN4 is responsible (Fig. 5A,  right) . Cs + caused both preparations to slow down: in the preparation including the SAN, the cycle length was prolonged by 31 ± 5% to 228 ± 16 ms (P b 0.05 versus control) and, in the preparation including the interatrial groove, the cycle length was prolonged by 23 ± 7% to 204 ± 18 ms (P b 0.05 versus control) (Fig. 5A,B) . This suggests that HCN4 plays an important role in pacemaking in both regions.
AV ring bundles and AVN
In the atria, there are rings of nodal-like cells around the atrioventricular valves (AV ring bundles) [5] [6] [7] [8] [9] [10] [11] [12] . Fig. 6A shows a Masson's trichrome stained sagittal section through the right and left atria and ventricles. Small nodal-like cells were present alongside both the tricuspid and mitral valves - in the boxed areas B and C. Fig. 6B (from boxed area B in Fig. 6A) shows that in the AV ring bundle around the tricuspid valve, the expression pattern of HCN4, Cx45 and Cx43 was similar to that of the SAN, although the amount of HCN4 and Cx45 was lower than in the SAN. The expression pattern of HCN4, Cx45 and Cx43 in the AVN (seen in Fig. 6A ) was similar to that of the AV ring bundle around the tricuspid valve (data not shown). This is not surprising, because the AVN can be thought of as part of the AV ring bundle [22] . Fig. 6C (from boxed area C in Fig. 6A) shows that in the AV ring bundle around the mitral valve, the expression of HCN4 was low or absent, whereas the expression of Cx45 and absence of Cx43 were similar to those in the AV ring bundle around the tricuspid valve. Similar results were obtained from four hearts.
Pulmonary veins
In four rat hearts, expression of HCN4 and Cx45 was not detected in the myocardial sleeves of the pulmonary veins, whereas Cx43 was expressed throughout the myocardial sleeves (Fig. 3D,E) . This expression pattern was same as that of the right and left atrial free walls. The absence of the HCN4 in the pulmonary veins is surprising, because in the embryonic mouse (ED 12) HCN4 mRNA has been observed in tissue that will give rise to the common pulmonary vein [23] . The presence of HCN4 in the pulmonary veins was, therefore, checked in another species. The abundance of HCN4 (and also HCN1) mRNA was measured in the proximal and distal parts of the pulmonary veins of the rabbit (Fig. 7A ) using quantitative PCR (it was not possible to immunolabel HCN4 protein as in previous experiments, because the antibody used was raised in the rabbit). In the proximal and distal parts of the rabbit pulmonary veins, the abundance of both HCN1 and HCN4 mRNA was comparable with that in right atrial muscle, i.e. the abundance of HCN4 mRNA in the pulmonary veins was low (Fig. 7B) . We have previously shown that, in the presence of ryanodine, rapid stimulation routinely induces pacemaker activity in the pulmonary veins from the rabbit [13] ; similar behaviour has been observed in the dog [24] . Fig.  7C shows action potentials recorded from the rabbit right superior pulmonary vein after exposure to 0.5 μM ryanodine. Following a rest period of 1 min, the preparation was stimulated at 3.3 Hz for 20 pulses; this resulted in a substantial depolarization of the membrane (Fig. 7C) . When 3.3 Hz stimulation was stopped, a train of spontaneous action potentials was recorded; a pacemaker potential was observed between action potentials (Fig. 7C) . Block of I f by 2 mM Cs + had no effect on this behaviour: in the absence and presence of Cs + , the train of spontaneous action potentials continued for 28.9 ± 5.7 s (n = 3) and 26.6 ± 3.6 s (n = 3), respectively (Fig.  7C ). This demonstrates that I f plays no role in pacemaker activity in the pulmonary veins.
Summary
Fig . 8A ,B shows ventral and dorsal views of the atria and summarises the distribution of HCN4 and Cx45 (and Cx43) observed in the present study. Nodal or nodal-like cells (as defined by the expression of HCN4 and Cx45 and lack of Cx43) looped around the ventral surface at the junction of the superior vena cava with the right atrium and extended from here down the intercaval region, both next to the crista terminalis (to form the SAN) and the interatrial groove. This roughly corresponds to the distribution of leading pacemaker sites observed in 18 preparations under control conditions (asterisks in Fig. 8C). Fig. 8A ,B also shows the expression of HCN4 and Cx45 in the AV ring bundles as well as the AVN; as indicated by the grey scale, expression of HCN4 in the SAN N expression in the AV ring bundle encircling the tricuspid valve N expression in the AV ring bundle encircling the mitral valve, whereas the expression of Cx45 was the same in the three tissues.
Discussion
In the present study, in the atrial muscle of the rat, Cx43 was expressed, whereas HCN4 and Cx45 were not expressed. However, HCN4 and Cx45 were expressed, whereas Cx43 was not expressed, in tracts of nodal-like cells extending down the interatrial groove and surrounding the tricuspid valve, as well as in the SAN and AVN (Fig. 8) . Evidence showed that the tract of HCN4-expressing cells in the interatrial groove has probable I f -dependent pacemaker activity and in some circumstances can be the leading pacemaker site (taking over from SAN) ( (Figs. 4, 5 and 8C) ).
Tract of nodal-like cells in interatrial groove
This study showed the presence of a tract of HCN4-positive/Cx43-negative/Cx45-positive small nodal-like cells extending downwards from the superior vena cava in the interatrial groove (Figs. 2 and 3) . The tract has not been described previously and is distinct from the SAN, which consists of a tract of HCN4-positive/Cx43-negative/Cx45-positive small nodal cells extending downwards from the superior vena cava next to the crista terminalis (Fig. 2) . By separating the interatrial groove from the SAN (Fig. 5) , the nodal-like cells in the interatrial groove were demonstrated to be capable of independent pacemaker activity. However, the pacemaker activity of the nodal-like cells in the interatrial groove was less robust than that of the SAN, because, in isolated preparations, they did not show pacemaker activity under control conditions (ISO was required), whereas the SAN did (Fig. 5) . This explains why in intact preparations under control conditions, the SAN was normally the leading pacemaker, although in some preparations the tract of nodal-like cells in the interatrial groove was the leading pacemaker site (Figs. 4C and 8C) . HCN4 is responsible for the Cs + -sensitive pacemaker current, I f , and it was demonstrated that the pacemaker activity of both the SAN and the nodal-like cells in the interatrial groove is Cs + -sensitive (Fig. 5) . Although under control conditions the pacemaker activity of the nodal-like cells in the interatrial groove was less robust than that of the SAN, in the presence of ISO the pacemaker activity of the nodal-like cells in the interatrial groove was as fast as that of the SAN (Fig. 5 ) and this perhaps explains why in intact preparations the leading pacemaker shifted from the SAN to the interatrial groove (Fig. 4) . In the dog, Boineau et al. [25] (see also [26] ) reported a consistent relationship between the leading pacemaker site and the heart rate: vagal stimulation decreased the heart rate and resulted in a caudal shift of the leading pacemaker site, whereas β-adrenergic stimulation increased the heart rate and resulted in a cranial shift. They suggested that different regions of the SAN are specialised for different heart rates. Our data are consistent with these observations.
The tract of HCN4-expressing nodal-like cells in the interatrial groove may be important pathologically: recently, Yamada et al. [27] showed that atrial tachycardia in a group of patients could be attributed to a focus in the interatrial groove on the rear wall of the right atrium. Perhaps the focus was a tract of HCN4-expressing nodal-like cells in the interatrial groove (as observed in the present study - Fig. 8) . In another study, Kistler et al. [28] showed that tachycardia, in one group of patients, could be attributed to a focus in the crista terminalis and, in a second group, to a focus in the interatrial septum. Perhaps in the first group of patients the focus was the SAN itself, whereas in the second group the focus was once again a tract of HCN4-expressing nodal-like cells in the interatrial groove.
AV ring bundles
It has been reported that in several mammalian species, including the human, myocytes in the atrioventricular annuli have automatic or triggered activities [5] [6] [7] [8] [9] [10] [11] [12] . The automaticity in rabbit tricuspid valve myocytes is sensitive to Cs + block of I f (Cs + results in a slowing of the beating rate [6, 7] ) and, furthermore, I f has been recorded from the tricuspid valve myocytes [7] . In the rabbit, pacemaker activity is faster in the tricuspid annulus than in the mitral annulus [5] . Consistent with these observations, in the present study, we demonstrated expression of HCN4 in the AV ring bundle of the tricuspid valve (Fig. 6 ). In the AV ring bundle of the mitral valve there was little or no expression of HCN4 (Fig.  6 ). This finding may account for the difference in pacemaker activity between the two annuli. In the AV ring bundles of both the tricuspid and mitral valves, we observed expression of Cx45 (and no expression of Cx43; Fig. 6 ) (cf. [8, 22] ). The tract of HCN4-expressing nodal-like cells around the tricuspid valve may again be important pathologically: Kistler et al. [28] showed that atrial tachycardia in another group of patients (see above) could be attributed to a focus in the right atrium around the tricuspid valve -this could correspond to a tract of HCN4-expressing nodal-like cells surrounding the tricuspid valve (as observed in the present study - Fig. 8 ).
Pulmonary veins
The pulmonary veins are capable of pacemaking and pulmonary vein cells can have a pacemaker potential [13] . In the present study, no significant expression of HCN4 protein or mRNA was observed in the pulmonary veins (Figs. 3D and 7B) and 2mM Cs + had no effect on spontaneous activity of the pulmonary veins (Fig. 7C) . Consistent with this, Ehrlich et al. [29] reported that I f is not present in dog pulmonary vein cells. These observations suggest that I f plays no role in the pacemaker activity of the pulmonary veins and in this case pacemaking must be the result of other ionic currents.
SAN and superior vena cava
In the present study, HCN4 and Cx45, but not Cx43, were expressed in the SAN as has been observed previously [17, 30] . In the present study, the SAN extended downwards from the superior vena cava next to the crista terminalis. In many experimental animals (rabbit, guinea-pig, monkey, mouse, cat, pig), the SAN has been reported to be located in this position [16, [31] [32] [33] [34] [35] ; for example, see our threedimensional anatomical model of the SAN of the rabbit [20] . In contrast, in the human, early studies by James [36] and Truex et al. [37] described the SAN as a discrete tissue at the junction of the superior vena cava with the right atrium (see well known diagrams of Netter). However, subsequently, in the human, it has been shown that the SAN can have a tail projecting down the crista terminalis [38] . Furthermore, the leading pacemaker site in the human (as well as dog and pig) can be located at many sites: as well as at the junction between the superior vena cava and the right atrium as expected from the work of James [36] and Truex et al. [37] , it can be located at any point between the superior and inferior vena cava along the line of the sulcus terminalis (a groove marking the border of the crista terminalis) in the rear wall of the right atrium [25, 26, [39] [40] [41] [42] . This widespread distribution of leading pacemaker sites is consistent with the distribution of SAN tissue observed in the present study (Fig. 8C) . The dog SAN is considered to be similar to the human SAN and, in the dog, total ablation of SAN pacemaker function requires the destruction of a block of tissue ∼ 4 cm long and 1.5 cm wide extending from the lateral junction of the superior vena cava with the right atrial appendage, along the crista terminalis to the inferior vena cava [26, 43] . Once again, this corresponds to the distribution of SAN tissue as described in the present study (Fig. 8) . The superior vena cava has been reported to have ectopic pacemaker activity [1] [2] [3] [4] ; it is possible that this is the result of abnormal pacemaker activity in the nodal cells that are wrapped around the ventral surface of the superior vena cava (Fig. 8) . The tract of nodal-like cells in the interatrial groove is a continuation of the tract of nodal cells wrapped around the ventral surface of the superior vena cava (Fig. 8) .
Specialised internodal pathways (between the SAN and AVN) have been proposed. Could nodal or nodal-like cells form the pathways? There was not a continuous tract of HCN4-expressing cells between the SAN and AVN (Fig. 8) and this is consistent with the finding that an increase in extracellular K + (which abolishes the action potential in atrial muscle but not in nodal tissue) blocks action potential transmission from the SAN to the AVN [44] .
AVN
In the present study, HCN4 and Cx45, but not Cx43, was expressed in the AVN (c.f. [15] ). The AVN can be considered to be part of the AV ring bundle of the tricuspid valve (Fig. 8A,B) . The posterior (or inferior) nodal extension is the slow pathway into the AVN, and the posterior nodal extension is the part of the AV ring bundle proximal to the AVN. Both the AVN and the posterior nodal extension had a similar expression of HCN4 and connexins as the rest of the AV ring bundle of the tricuspid valve (data not shown). Recently, we have shown that, after the destruction of the SAN, the junctional rhythm, which is Cs + -sensitive (i.e. I f -dependent), originates in the posterior nodal extension [15] .
Conclusion
In the atria, HCN4 is expressed in four structures: (i) a tract of nodal-like cells in the interatrial groove, (ii) a tract of nodal-like cells encircling the tricuspid valve, (iii) the SAN and (iv) the AVN. This will be of importance for normal and abnormal pacemaking in the atria.
